19848-57-8 Usage
General Description
1-(6-Methylpyrazin-2-yl)hydrazine is a chemical compound with the molecular formula C5H8N4. It is an organic compound that consists of a pyrazine ring with a hydrazine group attached at the 1-position. 1-(6-Methylpyrazin-2-yl)hydrazine is used in various chemical reactions and processes, including in the synthesis of pharmaceuticals and agrochemicals. It has also been studied for its potential use in coordination chemistry and as a ligand for metal complexes. Additionally, 1-(6-Methylpyrazin-2-yl)hydrazine may have applications in the development of new materials and catalysts. Overall, this compound has a range of potential uses and is an important building block in organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 19848-57-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,8,4 and 8 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 19848-57:
(7*1)+(6*9)+(5*8)+(4*4)+(3*8)+(2*5)+(1*7)=158
158 % 10 = 8
So 19848-57-8 is a valid CAS Registry Number.
19848-57-8Relevant articles and documents
QUINOLINE DERIVATIVES AS SMO INHIBITORS
-
Paragraph 0117; 0118, (2017/02/28)
Disclosed are quinoline derivatives as hedgehog pathway inhibitors, especially as SMO inhibitors. Compounds of the present invention can be used in treating diseases relating to hedgehog pathway including cancer.
Discovery of potent and selective dipeptidyl peptidase IV inhibitors derived from β-aminoamides bearing subsituted triazolopiperazines
Kim, Dooseop,Kowalchick, Jennifer E.,Brockunier, Linda L.,Parmee, Emma R.,Eiermann, George J.,Fisher, Michael H.,He, Huaibing,Leiting, Barbara,Lyons, Kathryn,Scapin, Giovanna,Patel, Sangita B.,Petrov, Aleksandr,Pryor, Kelly Ann D.,Roy, Ranabir Sinha,Wu, Joseph K.,Zhang, Xiaoping,Wyvratt, Matthew J.,Zhang, Bei B.,Zhu, Lan,Thornberry, Nancy A.,Weber, Ann E.
, p. 589 - 602 (2008/09/17)
A series of β-aminoamides bearing triazolopiperazines have been discovered as potent, selective, and orally active dipeptidyl peptidase IV (DPP-4) inhibitors by extensive structure-activity relationship (SAR) studies around the triazolopiperazine moiety.